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ABSTRACT 
A CORRELATIVE STUDY OF RESPIRATORY FUNCTIONS AND 
ALLERGIC ASPECTS IN SPRAY PAINTERS 
Occupational environmental exposures play an important role in variety of health 
effects and the chief mode of entry is by inhalation as dust or fumes. Spray painters are 
continuously exposed to vapours, harmful substances and toxic materials during 
working hours. The harmful effects of dusts on the lungs depend on number of factors 
such as chemical composition, fineness, concentration of dust in air, period of 
exposure, concentration of exposure and health condition of the person exposed. 
Exposure to harmful substances in spray painting can have short term effects such as 
respiratory tract irritation, shortness of breath, influenza-like symptoms, tightness of 
chest, nausea, headache, dizziness and long term effects include cancer, sensitisation 
of the respiratory system, asthma, abnormal reduction in lung function, emphysema 
and central nervous system dysfunction. Toluene diisocyanate (TDI), diphenyl-
methane diisocyanate (MDI), and hexamethylene diisocyanate (HDI) are the most 
frequently used diisocyanate monomers. Pulmonary function test (PFT) is a sensitive 
test to assess the effect of spray painting on lung functions. Determination of total IgE 
is useful as an aid in the diagnosis of allergic diseases. The electro chemi luminescence 
immunoassay ECLIA is intended for use on Elecsys and cobas e immunoassay 
analyzers. The Elecsys IgE II assay uses monoclonal antibodies specifically directed 
against human IgE. Aim of the study was to evaluate the changes in dynamic 
respiratory functions of spray painters using Easyone Diagnostic Spirometer, to 
measure immunoglobulin E (IgE) level, to calculate absolute eosinophil count (AEC) 
and to compare parameters of study group to that of control group. Parameters studied 
were Forced Vital Capacity (FVC) (lit), Forced Expiratory Volume in 1st second 
(FEV1) (%), FEV1/FVC, Mean Forced Expiratory Flow (FEF 25-75%) (lit/sec), Peak 
Expiratory Flow Rate (PEFR) (lit/min) and Maximum Voluntary Ventilation (MVV) 
(lit/min) followed by measuring level of IgE and Absolute Eosinophil Count. Spray 
painters of age group 25- 50 years, who are involved in spray painting for duration 
more than 2 years and controls not exposed to spray painting of age group 25- 50 years 
from Master health check- up clinic at Stanley Medical College are chosen for this 
study. After obtaining informed written consent from the subjects in their own 
language, pulmonary function test was recorded in research lab, Department of 
Physiology, Stanley Medical College using Easyone diagnostic spirometer. The entire 
procedure was explained and later demonstrated to the subjects satisfactorily. 
Interpretation of pulmonary function test parameters was done based on GOLD/ 
Hardie interpretation. After recording PFT, blood sample was collected from the 
subjects under strict sterile aseptic precautions. Data collected was stored and analyzed 
statistically by unpaired student t test using SPSS version 17.0. The data are expressed 
as Mean ± Standard deviation and P value < 0.05 is taken as significant. Of the total 30 
subjects in study group, the mean age in years is 45 ± 4, mean height in centimetres is 
158 ± 8, mean weight in kilograms is 73 ± 12 and mean BMI is 29 ± 4 and that of 30 
subjects in control group the mean age in years is 44 ± 4, mean height in centimetres is 
159 ± 6, mean weight in kilograms is 71 ± 10 and mean BMI is 28 ± 4. It was observed 
that there is a highly significant change in FVC (2.40 ± 0.31), FEV1 (2.16 ± 0.26) and 
significant change in FEV1/ FVC (0.90 ± 0.08) among study group when compared to 
that of control group FVC (3.29 ± 0.27), FEV1 (3.11 ± 0.28) and FEV1/ FVC (0.95 ± 
0.04). There is a highly significant change in PEF (4.80 ± 1.74) and MEF25- 75% (3.01 ± 
1.07) among study group when compared to that of control group PEF (6.46 ± 1.91) 
and MEF 25- 75% (4.47 ± 0.82). There is a highly significant change in MVV (82.35 ± 
20.07) among study group when compared to that of control group MVV (102.56 ± 
25.15). IgE (410 ± 20) and AEC (333 ± 22) are significantly increased in study group 
when compared to that of control group IgE (97 ± 41) and AEC (228 ± 90). Duration 
of exposure to spray painting and pulmonary function test has been correlated and 
found that there is a statistically significant negative correlation existing between 
MEF25- 75% and duration of exposure to spray paint. No significant correlation 
demonstrated between FVC, FEV1, FEV1/ FVC, PEF, MVV, IgE levels and AEC and 
duration of spray paint exposure. While correlating IgE levels and AEC to that of 
parameters of pulmonary function test we found that the correlation was not 
statistically significant. FVC, FEV1 and FEV1/ FVC are better indicators to 
differentiate obstructive or restrictive lung disease. Isocyanate exposure in spray paint 
produce occupational asthma which causes an obstructive type of lung disease 
substantiated by normal or decrease in FVC, decrease in FEV1 and decrease in FEV1/ 
FVC ratio. In our study, there is significant decrease in FVC, FEV1 and FEV1/ FVC 
ratio. There is a significant decline in PEFR in study group when compared to control 
group indicating a larger airway involvement due to spray paint. FEF25-75% is a better 
indicator of smaller airway disease. We found that there is a statistically significant 
change in FEF25- 75% and there was a strong negative correlation between FEF25-75% and 
duration of spray paint exposure indicating smaller airway involvement. MVV is more 
a sensitive indicator of airflow obstruction and in our study too shows a significant 
decrease in MVV when compared to control group emphasising the fact that 
obstructive airway disease is seen in isocyanate induced asthma. IgE levels were 
significantly elevated in our study group exposed to spray painting. AEC is 
significantly elevated in study group showing a strong relationship between isocyante 
exposure and allergic reactions. Correlation between duration of exposure to spray 
paint and IgE level and AEC in study group showed negative correlation, which was 
not significant statistically. This is due to the reason that the individual gets 
conditioned to the allergic aspect as the duration of spray paint exposure prolongs. We 
observe that measurement of pulmonary function test in individuals working in spray 
painting helps in early detection of any respiratory compromise and measuring IgE 
along with pulmonary function test serves as a sensitive indicator if done early during 
the period of exposure. Also measuring Absolute Eosinophil Count along with PFT 
and IgE serves as a strong evidence for allergic component involvement and bronchial 
hyperreactivity. In future, lung function test, IgE and AEC estimations may be a 
sensitive means to correlate isocyanate exposure and respiratory disease. 
Key words: Spray painters, Occupational asthma, di-isocyanate, TDI, MDI, HDI, 
pulmonary function test, spirometry, Immunglobulin E, ECLIA, Flow cytometry, 
absolute eosinophil count. 
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INTRODUCTION 
Occupational environmental exposures play an important role in 
many lung disorders. Exposure to air pollutants has a variety of health 
effects and the chief mode of entry of some of them is by inhalation as 
dust or fumes. Spray painters by virtue of their occupation are 
continuously exposed to vapours, harmful substances and toxic materials 
during working hours. 
The harmful effects of dusts on the lungs depend on number of 
factors such as chemical composition, fineness, concentration of dust in 
air, period of exposure, concentration of exposure and health condition of 
the person exposed. Most of the workers do not wear any personal 
protective masks, goggles, aprons, hand gloves and filters to protect 
themselves. 
Occupational health is defined as “Occupational health aiming at 
promotion and maintenance of the highest degree of physical, mental and 
social well being of workers in all occupations; the prevention among 
workers of departures from health caused by their working conditions; the 
protection of workers in their employment from risks resulting from 
factors adverse to health; the placing and maintenance of the worker in an 
occupational environment adapted to his physiological and psychological 
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equipment and to summarise the adaptation of work to man and of each 
man to his job” 1. 
SPRAY PAINT 
According to code of practice- spray painting, “Spray painting is a 
process by which air is driven across the mouth of a small outlet under 
such pressure as to draw the paint out and produce an air- paint mist from 
the jet of the spray-gun”. 
In addition, the paint may be fed under pressure to the gun. Spray 
painting may be carried out by hand or automatically. Airless spraying is 
a method by which pressure is applied directly to the paint, which is 
forced out of a nozzle. 
Hazardous substances are “substances that the manufacturer (or 
importer) has determined are hazardous, in accordance with the National 
Occupational Health and Safety Commission’s List of Designated 
Hazardous Substances or Approved Criteria for Classifying Hazardous 
Substances”. 
Normally, the substances can be identified as hazardous by their 
labels. Many substances encountered in spray painting are hazardous. 
They include paints, solvents, dusts, powders, lacquers, paint removers, 
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resins, adhesives, degreasers, surface preparation products, rust 
converters and rust removers 2. 
Exposure to harmful substances used in spray painting can have 
serious health effects. Exposure can occur through different ‘routes of 
entry’ into the body. Routes of entry include inhalation, skin contact, 
ingestion, eye contact and injection through high pressure equipment. 
Depending on the substance, the severity of the harm could range from 
minor skin irritation to chronic lung disease. 
Short term effects may include, respiratory tract irritation, 
shortness of breath, influenza-like symptoms, tightness of chest, nausea, 
headache and dizziness. 
Long term effects may include cancer, sensitisation of the 
respiratory system, asthma, abnormal reduction in lung function, 
emphysema and central nervous system dysfunction. 
Polyurethane (PUR and PU) is a polymer composed of a chain of 
organic units joined by carbamate (urethane) links. Polyurethane 
polymers are formed by reacting isocyanate with a polyol. 
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Di-isocyanates are bifunctional molecules used commercially to 
polymerise polyglycol and polyhydroxyl compounds to form 
polyurethanes. 
Di-isocyanates are low-molecular-weight compounds characterized 
by highly reactive NCO groups and are one of the most commonly 
identified causes of occupational asthma 3,4,5. 
Di-isocyanates are used as cross-linking agents in polyurethane 
products, such as foams, paints, lacquers, inks, insulating materials, 
varnishes, rubber modifiers, bonding and vulcanizing agents 6,7.  
Toluene diisocyanate (TDI), diphenyl-methane diisocyanate 
(MDI), and hexamethylene diisocyanate (HDI) are the most frequently 
used diisocyanate monomers. Toluene di-isocyanate and diphenyl-
methane di-isocyanate are generally less expensive and more reactive 
than other isocyanates. Toluene is a monomethyl derivative of benzene. It 
is used extensively as an industrial for paints and coatings, resins, oils and 
rubber. 
The most common isocyanate monomer found in aliphatic 
polyurethane paint is hexamethylene di-isocyanate and is the ingredient 
which has generated the majority of concern. 
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The hexamethylene di-isocyanate is present in the uncured 
polyurethane paint coating and may be released during thermal 
decomposition of cured polyurethane paint coatings. 
Spray painters exposed to hexamethylene di-isocyanate oligomer 
mixtures are among the occupational groups with the maximum incidence 
of occupational asthma in industrialized countries 8,9,10. 
Besides allergic asthma, isocyanate exposure may also induce 
irritant asthma, hypersensitivity pneumonitis and possibly accelerated 
lung function decline. The polyurethane products continue to increase, 
along with the increase in number of workers who are at risk for 
exposure. 
In the early years annual occupational asthma incidence was as 
high as 5 to 6%. The reduction of average toluene di-isocyanate 
concentrations below the 8-hour occupational exposure limit of 5 ppb 
(parts per billion) led to a decline in incidence of below 1%11. Conversely 
asthma symptom prevalence of up to 41% has been reported in toluene 
di-isocyanate users in less controlled environment and substitution of a 
different paint for one containing toluene di-isocyanate has halted an 
epidemic of asthma12. 
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Inhaled di-isocyanates have reported to cause four different 
respiratory reactions. 
1. Toxic bronchitis and asthma. Exposure to toluene di-isocyanate in 
an atmospheric concentration of 0.5 ppm (parts per million) causes 
irritation of mucosal surfaces, eyes, nose and throat 13.  
2. Bronchial asthma caused by sensitisation to di- isocyanates. 
3. Accelerated decline of Forced Expiratory Volume in 1 second 
(FEV1). 
4. Extrinsic allergic alveolitis, which has been reported particularly in 
workers exposed to diphenyl-methane di-isocyanate and 
hexamethylene di-isocyanate 14. 
Of these four, bronchial asthma caused by hypersensitivity to 
isocyanates has been the most frequently reported and is probably the 
most important both in terms of prevalence and morbidity.  
Agents that have been associated with induction of occupational 
asthma can be conveniently grouped into categories of high and low 
molecular weight compounds. All of these agents tend to sensitize the 
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individual, so that low ambient concentrations of the substance can 
ultimately cause significant bronchoconstriction. 
PATHOPHYSIOLOGY OF ISOCYANATE INDUCED LUNG 
DISEASE 
The harmfulness of an inhaled substance depends on its inherent 
toxicity, its ability to penetrate to the site at which it can exert its effects 
and the amount retained in the lung. Penetration depends on the ability of 
the particle to overcome the physical forces tending to bring it into 
contact with the walls of the airways namely sedimentation, impaction, 
interception, diffusion and electrostatic precipitation 15. 
Sedimentation or movement under the influence of gravity 
proceeds at a rate that depends on the density and the square of the 
diameter of the particle; thus large dense particles fall rapidly and are 
deposited primarily in the nose, mouth and larger airways. 
Impaction occurs when a particle fails to follow a change in 
direction of airflow and strikes the airway wall; it depends on the 
particle’s momentum so again large particles are filtered out by the larger 
airways. 
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Interception is a factor in the deposition of fibrous aerosols when 
the ends of long thin particles strike the airway wall. 
Diffusion occurs as a result of Brownian motion, due to 
bombardment of very small particles by gas molecules in the air, and is 
particularly important with respect to deposition on alveolar walls of 
particles less than 0.5 µm. It is also the mechanism whereby inhaled toxic 
gases exert their effects on the airways and alveoli. 
Electrostatic precipitation was until recently not thought to be 
important because of the conducting properties of mucus 16.  
Another representation of lung deposition patterns shows that the 
highest rate of alveolar deposition occurs with a particle size around 0.02- 
0.06 µm (20-60 nm). This is the size range of particles in fume and 
nucleation mode of ambient air pollution17. 
Particles above 10 to 15 µm in diameter, because of their settling 
velocities in air, do not penetrate beyond the upper airways. 
Particles below 10 µm in size are created by the burning of fossil 
fuels or high-temperature industrial processes resulting in condensation 
products from gases, fumes or vapours. These particles are divided into 
three size fractions on the basis of their size characteristics and sources. 
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Particles of approximately 2.5 to 10 µm (coarse-mode fraction) 
contain crustal elements such as silica, aluminium and iron. These 
particles mostly deposit relatively high in the tracheobronchial tree. 
Particles smaller than 2.5 µm (fine-mode fraction or accumulation 
mode) are carried to the lower airways depending on the number of 
particles and the surface area on which potential toxic agents gets 
deposited. 
The smallest particles, those less than 0.1 µm in size, (ultrafine 
fraction) make up the largest number of particles, which tend to remain in 
the airstream and deposit in the lung only on a random basis as they come 
into contact with the alveolar walls. 
Once deposited in the respiratory tract the fate of the particle 
depends on the body’s clearance mechanism and its ability to resist them. 
Larger particles deposited in the airways, are generally cleared efficiently 
within 24 hours by mucociliary mechanism18,19. Such cleared particles 
may be coughed up or swallowed. Particles reaching beyond the region of 
cilia and production of mucus are cleared much more slowly20. 
Deposition occurs predominantly at bifurcations of alveolar ducts21. The 
mechanism of particle removal involves ingestion by alveolar 
macrophages22 or type I alveolar epithelial cells23. Having ingested a 
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particle the type I alveolar cell either delivers it into the interstitial space 
of the alveolar wall where it can be taken up by interstitial macrophages 
or flow with interstitial fluid into the lymphatics or dies and passes into 
the alveolar lumen24. 
PICTURE – 1 : STRUCTURE OF AIRWAY 
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The macrophage also seems to have several options: it may migrate 
up by the mucociliary escalator impelled by flow of alveolar surfactant 
and move to the terminal airways due to viscosity gradient25. 
Alternatively it can pass between the alveolar epithelial cells temporarily 
unlocking the epithelial junctions by proteolytic enzyme action, into the 
interstitial space. It may then proceed into the lymphatics to pulmonary 
and hilar nodes or pass back into the airways at the end of the terminal 
bronchiole, through lymphatic sumps 23. 
The harm exerted by the particle once inhaled depends on its 
biological, chemical, physical properties and on amount inhaled. 
Biological factors include its ability to act as a sensitizer or to overcome 
attack by macrophages, provoke a primarily nasal reaction of a 
hypersensitivity type. 
Chemical factors include the effects of gases or particle surfaces on 
cell or lysosomal membranes. 
Physical factors apply when the particle is too large to be removed. 
In addition, recent studies of micro fine particles of less than 50 nm 
diameter have shown paradoxical toxicity in rats at inhaled 
concentrations too low to cause pathological effects. The same 
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concentrations inhaled in larger micrometre- sized respirable particle do 
not produce any toxicity26. 
This strongly suggests that physicochemical factors associated with 
particle surfaces may be responsible for toxicity in particles associated 
with air pollution and fumes such as those derived from welding fumes 
and metal cutting27. 
Finally the total mass of dust inhaled is clearly important in that the 
lung’s defences are evolved to enable removal of the modest amounts of 
particulate matter found in the ambient air and not the large amounts of 
inorganic matter that may be inhaled in the work place.  
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PICTURE – 2 : ANATOMY  OF RESPIRATORY SYSTEM 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
American Lung Association: Occupational Lung Diseases: An 
Introduction. New York, NY. Macmillan. 1979: pp 10. (5). 
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PULMONARY FUNCTION TEST 
Aromatic di-isocyantes, on a constant exposure cause a decrease in 
respiratory functions which can be assessed by a simple tool called 
spirometry, which measures their pulmonary function. Serial 
measurements are useful in assessment of the type and extent of lung 
dysfunction, detection of early evidence of lung disease, longitudinal 
surveillance in occupational settings; follow up of response to therapy, 
determining the prognosis and disability evaluation28. 
Pulmonary function test (PFT) is a sensitive test to assess the effect 
of spray painting on lung functions. Clinical evaluation of lung function 
and the study of static lung mechanics begin with the measurement of 
lung volumes and the factors that determine these volumes. All lung 
volumes are subdivisions of total lung capacity. 
Total Lung Capacity (TLC) is the total volume of air that can be 
contained in the lung. Lung volumes are reported in litres either as 
volumes or as capacities. A capacity is composed of two or more 
volumes. Four pulmonary volumes and four pulmonary capacities can be 
deduced. The lung volumes are,  
 30 
1. Tidal volume: It is the volume of air inspired or expired with every 
breath and is approximately 500 ml in adult males. 
2. Inspiratory reserve volume: It is the volume of air inspired 
maximally over end- inspiration. It is approximately 3.0 L. 
3. Expiratory reserve volume: It is the volume of air that can be 
expired maximally from end- expiration. It is approximately 1.1 L. 
4. Residual volume: It is the volume of air that remains in the lung 
after a forceful expiration. It is approximately 1.2 L. 
5. Inspiratory capacity: It is the tidal volume plus inspiratory reserve 
volume. 
6. Functional residual capacity: It is the residual volume plus 
expiratory reserve volume. 
7. Vital capacity: It is the inspiratory reserve volume plus tidal 
volume plus expiratory reserve volume. 
8. Total lung capacity: It is vital capacity plus residual volume.  
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PICTURE – 3 : RESPIRATORY VOLUMES AND CAPACITIES 
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Pulmonary Function Tests including spirometry, lung volumes, and 
diffusing capacity are the most important tools to assess functional 
respiratory status in patients with occupational lung disease, as with non 
occupational diseases. PFT is important for evaluating dyspnea, 
differentiating obstructive from restrictive airway defects and assessing 
the degree of pulmonary impairment. Many lung volumes are measured 
with a spirometer, but neither the functional residual capacity nor the 
residual volume can be obtained by simple spirometry. 
In clinical practice, while performing the pulmonary function test, 
along with the measurement of the various volumes and capacities, 
another parameter that is determined is forced expiratory volume (FEV). 
Forced Expiratory Volume (FEV): 
The volume of air that can be forcibly expired in the first second is 
called FEV1 and the volume that can be expired in 2 second is called 
FEV2 and the volume expired in 3 second is called FEV3. Normally the 
entire vital capacity can be forcibly expired in 3 seconds. In normal 
individuals FEV1/ FVC is approximately 0.8, which means that 80% of 
the vital capacity can be forcibly expired in the first second. 
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Forced Vital Capacity (FVC): 
Most important dynamic lung volume which is measured clinically 
as an index of pulmonary function is forced vital capacity (FVC). FVC is 
the maximum amount of air that is forcefully breathed out after inflating 
the lung to the maximum by maximum inspiration. 
FVC and FEV1 are helpful in the diagnosis of lung disease. FEV1/ 
FVC can be used to differentiate between various types of diseases. For 
instance, in obstructive lung disease like asthma both FEV1 and FVC are 
decreased, but FEV1 is decreased more than FVC. In fibrosis of lung, 
which is a restrictive lung disease, both FEV1 and FVC are decreased, but 
FEV1 is decreased less than FVC. Thus in fibrosis FEV1/ FVC ratio 
actually increases29,30. 
Table 1: Interpretation of reports in Pulmonary Function Test: 
Interpretation FEV1 FVC FEV1/ FVC 
Normal person normal normal normal 
Airway obstruction low 
normal or 
low low 
Lung Restriction low low normal 
Combination of 
Obstruction/Restriction low low Low 
Adapted from Chronic Obstructive Pulmonary Disease, 5th Edition (1977). American Lung 
Association.  
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Table 2: Comparison of PFT report in obstructive and restrictive 
lung disease: 
Interpretation Obstructive Pattern Restrictive Pattern 
Normal FEV1/ FVC  ≥ LLN FVC ≥ LLN 
Borderline 
FEV1/ FVC < LLN & FEV1 ≥ 
LLN - 
Mild FEV1 < 100 & ≥ 70% Pred 
FVC < LLN & ≥ 
70% Pred 
Moderate FEV1 < 70 ≥ 50% Pred 
FVC < 70 & ≥ 50% 
Pred 
Severe FEV1 ≤ 50% Pred FVC ≤ 50% Pred 
LLN- Lower Limit of Normal. 
Adapted from American Thoracic Society : Lung function testing : Selection of 
reference values and interpretative strategies (1991). American Review of 
Respiratory Diseases 144 : 1202 – 1218. 
FLOW- VOLUME LOOP 
A newer way of measuring lung function clinically is the flow-
volume curve or loop. A flow- volume curve or loop is created by 
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displaying the instantaneous flow rate during a forced maneuver as a 
function of the volume of gas. This instantaneous flow rate can be 
displayed both during exhalation (expiratory flow-volume curve) and 
during inspiration (inspiratory flow-volume curve). Expiratory flow rates 
are displayed above the horizontal line and inspiratory flow rates below 
the horizontal line. The flow-volume loop yields data for three main 
pulmonary function tests: 
1. Forced Vital Capacity (FVC); 
2. The greatest flow rate achieved during the expiratory maneuver, 
 called the Peak Expiratory Flow Rate (PEFR), and 
3. Expiratory flow rates. When the expiratory flow-volume curve is 
divided into quarters, the instantaneous flow rate at which 50% of 
the VC remains to be exhaled is called the FEF50 (also known as 
the Vmax50), the instantaneous flow rate at which 75% of the VC 
has been exhaled is called the FEF75 (Vmax75), and the 
instantaneous flow rate at which 25% of the VC has been exhaled 
is called the FEF25 (Vmax25).  
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PICTURE  – 4 : FLOW VOLUME LOOP 
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DETERMINANTS OF MAXIMAL FLOW 
The shape of the flow-volume loop reveals important information 
about normal lung physiology that can be altered by disease. Inspection 
of the flow-volume loop reveals that the maximum inspiratory flow is the 
same or slightly greater than the maximum expiratory flow. 
Two factors are responsible for the maximum inspiratory flow. 
First, the force that is generated by the inspiratory muscles decreases as 
lung volume increases above RV. Second, the recoil pressure of the lung 
increases as the lung volume increases above RV. This opposes the force 
generated by the inspiratory muscles and reduces maximum inspiratory 
flow. However, airway resistance decreases with increasing lung volume 
as the airway caliber increases. 
The combination of inspiratory muscle force, recoil of the lung and 
changes in airway resistance causes maximal inspiratory flow to occur 
about halfway between TLC and RV. 
During exhalation, maximal flow occurs early (in the first 20%) in 
the maneuver, and flow rates decrease progressively toward RV. Even 
with increasing effort, maximal flow decreases as RV is approached. This 
is known as "expiratory flow limitation" and can be demonstrated by 
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asking an individual to perform three forced expiratory maneuvers with 
increasing effort. As effort increases, peak expiratory flow increases. 
However, the flow rates at lower lung volumes converge; this indicates 
that with modest effort, maximal expiratory flow is achieved. 
No amount of effort will increase the flow rates as lung volume 
decreases. For this reason, expiratory flow rates at lower lung volumes 
are said to be "effort independent" and "flow limited" because maximal 
flow is achieved with modest effort and no amount of additional effort 
can increase the flow rate beyond this limit. In contrast, events early in 
the expiratory maneuver are said to be "effort dependent"; that is, 
increasing effort generates increasing flow rates. In general, the first 20% 
of the flow in the expiratory flow-volume loop is effort dependent 31,32. 
IMMUNOLOGICAL TESTING FOR LUNG DISEASE 
The application of immunological tests in the investigation of 
occupational lung disease has widened because of development of 
reliable methods for identification of specific IgE antibody in serum. 
Specific IgE has also been identified in the sera of patients with asthma 
caused by some low molecular weight chemicals; particularly acid 
anhydrides 33 and reactive dyes 34. 
Di-isocyanates, a low molecular weight compounds used by 
polyurethane workers, plastic, foundry and spray painters form an 
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isocyanate- protein complex. These agents also tend to cause IgE- 
dependent broncho constriction. 
Specific IgE or IgG antibodies produced in these individuals are 
directed at the low molecular weight compound coupled to a protein 
within serum. There is also evidence that low molecular weight 
compounds induce asthma through IgE- independent mechanisms, 
possibly by affecting T lymphocytes directly as for isocyanates 35. 
Immunoglobulins are the products of differentiated B cells and 
mediate the humoral arm of the immune response. The primary functions 
of antibodies are to bind specifically to antigen and bring about the 
inactivation or removal of the offending toxin, microbe, parasite, or other 
foreign substance from the body 36. 
Determination of total IgE is useful as an aid in the diagnosis of 
allergic diseases. Immunoglobulin IgE plays an important role in 
immunological protection against parasitic infections and in allergy. Type 
I hypersensitivity is characterized by the occurrence of allergic reactions 
immediately following contact with an allergy initiating antigen 
(allergen). The binding of the allergen to sensitized mast cells or 
basophilic cells leads to cross linking of the IgE on the cell membrane 
and causes cell degranulation. 
 
 40 
ECLIA (ELECTRO CHEMI LUMINESCENCE IMMUNOASSAY) 
The electro chemi luminescence immunoassay ECLIA is intended 
for use on Elecsys and cobas e immunoassay analyzers. The Elecsys IgE 
II assay uses monoclonal antibodies specifically directed against human 
IgE. 
Immunoassay is for in vitro quantitative determination of 
immunoglobulin E in human serum and plasma. Test principle is 
sandwich principle and total duration of assay is 18 minutes. 
1st incubation: IgE in the sample a biotinylated monoclonal IgE 
specific antibody and a monoclonal IgE specific antibody labelled with a 
ruthenium complex form a sandwich complex. 
2nd incubation: After addition of streptavidin coated microparticles, 
the complex becomes bound to the solid phase via interaction of biotin 
and streptavidin. The reaction mixture is aspirated into the measuring cell 
where the microparticles are magnetically captured onto the surface of the 
electrode. Unbound substances are then removed. Application of a 
voltage to the electrode then induces chemiluminescent emission which is 
measured by a photomultiplier. Results are determined via a calibration 
curve which is instrument- specifically generated by 2- point calibration 
and a master curve provided via the reagent barcode 37.  
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PICTURE – 5 : BASIC PRINCIPLE OF ECLIA 
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The IgE concentration in serum is normally very low (<0.001% of 
the total serum immunoglobulin). The IgE concentration is age 
dependent, with the lowest values being measured at birth. Its 
concentration gradually increases and becomes stabilised between the 
ages of 5- 7 years, although the IgE values vary greatly within particular 
age groups 38. Recommended threshold values are 39,40,41: 
Table 3: Threshold values for IgE for different age groups: 
Age group IU/mL ng/mL 
Neonates 1.5 3.6 
Infants in 1st year of life 15 36 
Children aged 1- 5 years 60 144 
Children aged 6- 9 years 90 216 
Children aged 10- 15 years 200 480 
Adults 100 240 
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ABSOLUTE EOSINOPHIL COUNT 
Cells of the eosinophilic series which normally make up about 3% 
of nucleated marrow cells mature in the bone marrow through stages 
similar to those of the granulocytic series. These have revealed a mean 
marrow transit time of 5.5 days, an intravascular compartment made up 
of a marginal pool and a circulating pool of equal size, and an 
intravascular half time of about 8 hours. 
For each circulating eosinophil, 100 are reportedly present in the 
tissues where they are found primarily in the skin and in the submucosa 
of the respiratory, gastrointestinal and genitourinary tracts. The mature 
eosinophil contains a bilobed nucleus and distinctive large granules 
which stain orange- red using Wright’s stain.  
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PICTURE – 6 : EOSINOPHIL IN A SMEAR 
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The eosinophil is considered to be a homeostatic regulator of 
inflammation that attempts to suppress inflammatory tissue reactions and 
to prevent the excessive spread of inflammation. They proliferate in 
response to antigenic stimulation and contain substances that inactivate 
factors released by mast cells and basophils. The basophil surface 
membrane contains receptors for the Fc fragment of IgE molecules. 
In acute allergic reactions a specific antigen reacts with IgE bound 
to basophils; and the basophils release their granule contents which 
include the allergic mediator, histamine. A related cell found in the 
tissues, the mast cell also possesses metachromatic granules containing 
histamine and surface membrane receptors for IgE. 
Mast cells contain or can synthesise multiple mediators of immune 
and inflammatory responses; histamine, prostaglandins, leukotriens, 
platelet activating factor, proteases and other lysosomal enzymes and 
materials affecting chemotaxis of eosinophils and neutrophils. Through 
their activation and degranulation after the binding of antigen to IgE on 
the surface membrane, mast cells play a central role in triggering 
immediate hypersensitivity reactions. They also participate in 
inflammatory responses and tissue repair 42. 
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FCM (FLOW CYTOMETRIC ANALYSIS) 
Flow cytometric analysis (FCM) has allowed detailed insights into 
the cellular biology of normal, reactive and neoplastic tissues. In its most 
general form, FCM would include any instrument that analyses a stream 
of individual cells from a cell suspension. 
However, in current usage the term flow cytometer means an 
instrument that interrogates individual cells by light so as to determine 
intrinsic (light scatter/ cell size/ and granularity) and extrinsic 
(fluorescence/ antibody, and nucleic acid dye binding) characteristics of 
the cells. The flow cytometer is a sophisticated mixture of fluidics, optics, 
light detectors and computers. 
The cell suspension is funnelled by the instrument into a single cell 
stream, which passes through the laser light. There is a characteristic 
scattering of the laser light by the cells that gives information of intrinsic 
cellular parameters. Some incident laser photons pass into the cytoplasm 
and are deflected by cytoplasmic granules or the cells 43. 
  
 47 
 
 
 
 
 
 
 
 
 
REVIEW OF LITERATURE 
  
 48 
REVIEW OF LITERATURE 
OCCUPATIONAL ASTHMA 
Occupational asthma (OA) is defined as, “asthma caused by or 
substantially made worse by agents inhaled in the occupational 
environment” 44. 
Di-isocyanates have been the most commonly identified causing 
agent for OA in industrialized areas. Asthma among di-isocyanate 
exposed workers is due to a high level of irritant exposure at work or by 
sensitization to di-isocyanates. Alternatively, asthma may be coincidental 
or may be aggravated by work exposure 45. 
Risk of occupational exposure to isocyanates is increasing 
substantially because of the rapidly expanding use of coating materials 
(paints), polyurethane foam manufacturing, and binders 46,47. Spray paint 
contains isocyanate a low-molecular-weight compound. 
Spray painting is a process by which exposure to isocyanates can 
be high. This spray paint creates fine mists or droplets of paint that may 
stay suspended in the air for a short period of time there by increasing the 
risk of inhalation, eye and skin exposure48. Some examples for di-
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isocyanates are TDI (Toluene Di-Isocyanate), MDI (Methylene Diphenyl 
Di-isocyanate), and HDI (Hexamethylene Di-Isocyanate). 
Compared with occupational asthma caused by other agents, those 
with occupational asthma due to di-isocyanates had a significantly earlier 
onset of asthma49,50. A follow-up study for 6 years was conducted in 
which the impairment correlated well with the frequency of high peak 
exposure to hexamethylene di-isocyanate. It was concluded in a study 
that occupational asthma is common disorder among automobile painters 
and duration of exposure has a significant effects on occupational asthma 
occurrence 51,52. 
Exposure to di-isocyanate monomers has been assessed in various 
epidemiologic studies. In the majority of these studies mean or maximum 
exposure levels are reported for a population in which a measure of 
disease frequency is investigated 53- 59. 
It is likely that humans have suffered from occupational asthma 
since the change from hunting to agriculture as a means of providing 
food. However the first recorded mention of breathlessness among 
handlers of grain was by Ramazzini in 1713, who is the father of 
occupational medicine 60. 
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The harmful effects of mining probably also date back to 
prehistory when humans first started to dig underground for flints to 
make arrowheads and axes and thus exposed themselves to quartz dust. 
Occupational exposure was also known to cause asthma occasionally 61. 
PULMONARY FUNCTION TEST 
Although Humphrey Davy had determined his own lung volume 
using hydrogen as the test gas in 1800, it was not until the 1840s that 
John Hutchinson laid the groundwork for modern pulmonary function 
testing: he devised a spirometer and used it to determine the subdivisions 
of the lung in a large number of healthy subjects, relating the 
measurements to height and age62. A spirometer used as early as 1846 by 
Hutchinson was a light bell- shaped container which is immersed in a 
water tank to form a seal. Modern modifications include dry spirometers 
made with bellows or a piston in a large cylinder. These often have an 
electrical output. As the bell moves up during exhalation the pen moves 
down marking the chart. In the tracing, the subject first breathed normally 
and the excursion of the pen gave the tidal volume29. Next he made a 
maximal inspiration followed by a maximal expiration. Normal breathing 
was then resumed. 
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Von Neergaard and Wirz, Rohrer developed and tested 
experimentally concepts involving pressures, flows and volumes. The full 
significance of Rohrer’s work was not appreciated until the publications 
by Fenn and his group at the University of Rochester starting in the 1940s 
63,64. 
Fuchs and Valade in 1951 were the first to recognize that 
isocyanate exposure causes respiratory diseases and later on numerous 
studies have been carried out among paint works 65. 
Wegman et al in 1977 reported on the chronic effects of toluene di-
isocyanate, stated that there was a significant association between acute 
and chronic exposure to toluene di-isocyanate  and decrement in FEV1, 
and concluded that exposures to toluene di-isocyanate  at 0.003 ppm or 
higher is unsafe 66. 
Karol et al in 1982, studied in sensitized guinea pigs and sensitized 
worker and found a leading hypothesis concerning the pathogenesis of 
toluene di-isocyanate- OA, which is that toluene di-isocyanate acts as a 
hapten and undergoes nucleophilic addition reactions in vivo with airway 
proteins 67. 
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Chan –Yueng et al in 1986 reported that approximately 5 – 10 % of 
workers exposed to toluene di-isocyanate develop asthma and the 
asthmatic symptoms develop in weeks or months after the start of 
exposure. In sensitised individuals, exposures as low as < 0.005 ppm, 
may induce an attack of asthma68. They reported that sensitivity to 
toluene di-isocyanate can persist even for many years in the absence of 
occupational exposure and suggested that some patients with toluene di-
isocyanate induced asthma do not recover from their disease even after 
being removed from isocyanate exposure. Moreover, continuous 
exposures to toluene di-isocyanate in sensitised patients led to further 
deterioration in lung function and increase in non-specific bronchial 
reactivity. 
Banks et al in 1986 in his study discussed the adverse respiratory 
effects due to the isocyanates and reported that the respiratory impairment 
in association with exposure remains inadequate69. 
Rosenberg and Gamier in I986, described a technique of using a 
medical history questionnaire followed by the application of lung 
function tests in a follow-up study on isocyanate induced asthma cases. 
This study was multidimentional in nature and hence later a similar 
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approach was adopted by using a questionnaire followed by spirometric 
testing70. 
Mapp et al in 1988 showed that paint workers developed asthmatic 
reaction after exposure to isocyanate71. 
The Surveillance of Work related and Occupational Respiratory 
Diseases (SWORD) - a national scheme of UK was set up in 1989 by 
Professor Corbett McDonald.  In 1989, 2101 cases of occupational lung 
disease were reported72. The overall annual incidence of occupational 
asthma during 1989 and 1990 was 22 per million working population 73. 
The occupational sets with the highest incidence, was coach and spray 
painters with 658 rate 106/year. 
Baur in his study about new aspects of isocyanate asthma done in 
1990 in Germany found that when inhalation challenge test was done 
with isocyanates 14% of symptomatic persons were immunologically 
sensitized and concluded that at or above threshold limits there is a risk of 
deterioration in lung function even in asymptomatic workers74. 
A 6 year follow-up study by Torling et al in 1990 found that, 
compared to the smoking control subjects, the smoking spray painters had 
greater yearly reduction in FVC, FEV1, and VC75. 
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Berube et al in 1991 showed that changes in peak flow are 
proportionally less than the FEV, in the same individual with asthma 76. 
Gannon et al in 1991 in a preliminary report of a surveillance 
scheme of occupational asthma in the West Midlands in the United 
Kingdom, found that the top four agents causing incidents of 
occupational asthma were isocyanates, colophony, flour and oil mist and 
these exposures closely matched the top four occupations spray painters, 
solderers, machine tool operators and bakers77. 
In June 1992 in South Africa, according to Government Notice 
576, the Compensation Commissioner acknowledged the importance of 
isocyanate induced asthma and placed it on the second schedule of listed 
compensatable diseases78. 
In 1992 a sampling scheme was introduced and the annual 
incidence estimated at 350079. 
Park et al in 1992 found that toluene di-isocyanate is the most 
common cause of OA in developing countries, with a prevalence of 2.9- 
13% in exposed workers. Burge in 1993 discusses the urgent need to have 
linear calibration of peak flow meters which may remove some of the 
confounding factors and concludes that methods are needed to increase 
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the sensitivity of serial peak flow measurements which should be 
achievable with the use of a computer diagnostic aid 80. 
Vandenplas et al in 1993 found that every isocyanate should be 
considered hazardous regardless of its molecular form or volatility 3. 
Swuste et al in 1994 presented a report in World Health 
Organization on hazard prevention and control in the workplace and 
launched the “Prevention and Control Exchange (PACE) Initiative with 
the following long term objectives: 
 To promote awareness and political will concerning the need for 
prevention and control as a priority element of occupational health 
programmes, and 
 To strengthen or develop, at the national level, technical and 
managerial capabilities for the utilization of successful approaches 
to the prevention and control of health hazards in the workplace, 
integrated into efficient and sustainable programmes, emphasizing 
anticipated preventive action, source control, safe work practices, 
workers’ participation and environmental protection 81. 
Randolph et al, in 1997, in his study about evaluating respiratory 
health status of automotive spray painters exposed to paints containing 
 56 
hexamethylene Di-isocyanatesin the greater Durban area, found that even 
though decline in FEV1 appear to be a suitable predictor of occupational 
asthma, in some cases it was found that the forced expiratory flow rate 
(FEF 25- 75 %) was a more sensitive indicator of early changes in the small 
airways. This study concluded that PEFR measurements are inadequate to 
serve as an early warning indicator of possible occupational asthma. 
Moreover immunological tests showed no correlation with declines in 
FEV1. This study demonstrates the difficulties in correlating 
immunological status with clinical and lung function findings in workers 
exposed to hexamethylene di-isocyanate, as a means of predicting 
occupational asthma. Randolph et al recommended routine spirometric 
lung function testing of all spray painters, the use of high volume- low 
pressure spray guns and the wearing of positive pressure airline masks, 
regular monitoring of spray booths, measurement of hexamethylene di-
isocyanate concentrations, airflow velocities and airflow patterns within 
the booth and implementation and enforcement of stricter control 
measures 82. 
Ogden and Topping in 1997 defined the occupational exposure 
limits (OEL) for airborne chemicals in Britain and concluded that 
exposures below the OELs do not mean that all workers are protected 83. 
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Vincent in 1998, stated that Occupational Exposure Limits (OELs) 
are a key element in risk management and are often incorporated in legal 
standards84. Although obvious exposure to known harmful agents should 
be controlled regardless of any existing regulation, establishment of a 
control limit often draws attention to a substance. Occupational exposure 
limits are usually expressed in one of the following forms: 
 Time-weighted average concentration (TWA), which is the average 
concentration over a full shift, usually 8 hours. 
 Ceiling concentration, which is an instantaneous concentration (in 
so far as this can be measured) not to be exceeded at any time. 
 Short-term exposure limits (STEL), which is the average 
concentration over a specified time, e.g. 15 minutes 85. 
Asthma which accounted for 28% of cases was the single most 
common diagnostic category. Isocyantes have consistently been the most 
commonly reported cause accounting for 20% of cases. In Britain at 
present isocyanates seem to be the most common cause of occupational 
asthma and isocyanate asthma continues to provide a typical example of 
asthma attributable to occupational chemicals86. The results have been 
conflicting and have stimulated much controversy. A major multicentre 
surveillance programme in Britain revealed no hint of a copd effect, while 
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study of a single isocyanate producing plant in the USA suggested a 
crippling occupationally induced mean decline in FEV1 exceeding 
100ml/year 87,88. 
Diem and colleagues conducted a 5 year investigation of workers 
in a new toluene diisocyanate manufacturing plant included an extensive 
series of isocyanate exposure measurements, from which the workforce 
was usefully separated into categories of low –average cumulative 
exposure and high – cumulative exposure 89. The high exposure group did 
show a significantly greater annual decline in FEV1 than the non- 
smokers of low exposure group. Thus the investigation suggested a 
modest excessive decline in FEV1 as a consequence of either isocyanate 
exposure or smoking, without there being any additive or multiplicative 
effects. 
One study reported persistent respiratory symptoms in 83 percent 
of workers who have been away from isocyanate exposure for 4 years. 
Another study demonstrated that 7 of 12 subjects with toluene di-
isocyanate- induced asthma continued to have non- specific airway 
hyperreactivity 2 years after removal from the work environment 90. 
Exposures to a number of organic dusts or chemical agents capable of 
producing occupational asthma result in pronounced obstructive patterns 
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of pulmonary dysfunction that may be reversible. Measurement of change 
in forced expiratory volume (FEV1) before and after a working shift can 
be used to detect an acute inflammatory or bronchoconstrictive response. 
An acute decrement of FEV1 over the first work shift of the week is a 
characteristic feature of exposure to spray paint among workers. 
Peters et al in 1975, Mapp et al in 2001 and Park et al in 2002, in 
different studies proved that three di-isocyanates cause occupational 
asthma (OA): toluene diisocyanate (TDI), 4, 4-diphenylmethane 
diisocyanate (MDI), and 1,6-hexamethylene diisocyanate (HDI) 91- 93. 
Becklake et al in 2006 proved that BHR is closely related to 
variable airway obstruction and is usually considered a hallmark of 
asthma in epidemiological studies. Specific IgE was found in only one of 
the 19 workers with both BHR and asthma-like symptoms and in none of 
the nine workers with both BHR and an FEV1/ FVC ratio of 70% 94. 
Ye YM et al in 2006 concluded that the pathogenic mechanisms of 
isocyanate induced asthma remain incompletely understood and no 
reliable method of serological testing has been established 95. 
Pronk, Raulf-Heimsoth et al in 2007, concluded that asthma-like 
and COPD-like symptoms are associated with isocyanate exposure level 
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in workers exposed to mainly hexamethylene di-isocyanate oligomers in 
the spray paint. Pronk found that exposure to isocyanates is associated 
with bronchial hyperresponsiveness (BHR) which is the hallmark of 
asthma. The FEV1/ FVC ratio and several flow parameters were 
significantly lower in spray painters compared with other workers. In this 
study, a clear and positive association was found between exposure to 
isocyanate oligomers and BHR 96. 
Similar findings were revealed by Ould-Kadi et al in 2007, who 
found lowered FEV1 in solvent exposed group of workers than the control 
group 97. 
Chattopadhyay et al in 2007, in 2.5 years follow-up study observed 
that pulmonary function parameters of isocyanate exposed workers for 
long duration were reduced even in very low concentration car painting 
and automobile painting workers 98. 
Nmai et al in 2011, in his article summarized that a potential 
biomarkers is essential for isocyanate induced asthma, based on different 
mechanisms, including immunologic, genetic neurogenic and protein 
markers and concluded that the detection of serum specific IgE or IgG is 
helpful even though this alone is not sensitive enough to serve as a bio 
marker. However it is certainly useful for confirming isocyanate specific 
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type I hypersensitivity, documenting exposure and monitoring subclinical 
conditions 99. 
In guidelines for controlling health hazards in painting operations 
in 2012 US Army Public Health Command Technical Guide, suggested 
that in sufficient concentrations, hexamethylene di-isocyanate  may cause 
acute pulmonary symptoms to include cough, shortness of breath, pain on 
respiration, increased sputum production, and chest tightness. In a small 
percentage of the workforce, it may produce asthmatic symptoms through 
an allergic, immunoglobulin E-mediated mechanism. Sensitive 
individuals may exhibit a decrease in forced expiratory volume in 1 
second (FEV1) on pulmonary function testing after being exposed during 
the work shift, as compared to pre shift values. A longitudinal study of 
workers exposed to toluene diisocyanate, suggests that low level for 
chronic exposures may result in an increased decrement in pulmonary 
function 100. 
Metwally et al in 2012 101 and Zailina et al in 2013 102 in different 
studies assessed pulmonary function of paint industry workers. 
Bishara et al in 2013, studied effect of flour mill dust on pulmonary 
function and effect of duration of exposure and found a significant 
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change in FVC and FEV1 and no significant change as duration of 
exposure increases 103. 
Mandal et al in 2013, while assessing the pulmonary function of 
paint industry workers from west Bengal found that there is significant 
correlation between pulmonary functions and duration of exposure to 
solvents and dust and found that most paint workers have restrictive 
pulmonary function impairment 104. 
IMMUNOGLOBULIN E (IgE) 
There are studies suggesting that isocyanates may interact directly 
with elements that modulate inflammation. Because these compounds are 
very reactive they may affect membrane receptors or enzymes involved in 
inflammatory pathways. One study has demonstrated specific IgE and 
IgG antibodies to isocyanates coupled to human serum albumin in sera of 
individuals with symptoms and positive inhalation challenge test with 
isocyanates 90. 
Johansson et al in 1968 and Barbee et al in 1981, found that nearly 
50% of the allergic subjects have the total IgE concentrations that are two 
standard deviations above the mean of a normal control group 105,106. 
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In a study by Pezzini in 1984, they found a specific IgE-mediated 
response was evaluated in twenty-eight workers exposed to toluene di-
isocyanate or diphenyl-methane di-isocyanate. The results suggest an 
association between the presence of specific IgE, early asthmatic 
symptoms and heavy episodic exposure 107. 
Patterson et al in 1987 found that isocyanate induced asthma is IgE 
mediated, but presence of a specific diisocyanate IgE has been shown 
only in a few workers with symptoms 108. 
Musk, Peters and Wegman in 1988 stated that specific IgE 
antibodies to isocyanates have been reported but specific IgE to 
diisocyanate conjugates have not been identified109. 
At the same time Grammer et al in 1988 reported on a study of 150 
spray painters’ measurements of ambient isocyanate levels and 
measurements of serum antibody to hexamethylene di-isocyanate bound 
to human serum albumin were evaluated 57. 
Roy Patterson et al in 1990 studied immunoassay for three 
isocyanates, and found high levels of IgG and IgE antibodies for 
hexamethylene di-isocyanate - HSA and toluene di-isocyanate -HSA in a 
34 year old individual who presented with hemoptysis, dyspnea and 
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bilateral opacities which progressed to respiratory failure. He proposed 
that the pathogenesis of this case of hemorrhagic pneumonitis is 
immunologic because of uncontrolled exposure to hexamethylene di-
isocyanate  and toluene di-isocyanate  110. 
Agha et al in 1997 proved in their study that among all age groups, 
difference between mean IgE levels between allergic subjects and 
controls was significant 111. 
Rosemary et al in 1998 investigated the utility of specific IgE 
measurement in the diagnosis of isocyanate- induced asthma. 58 of 101 
patients referred for investigation were diagnosed as having isocyanate-
induced occupational asthma by means of history, serial peak flow 
records, and bronchial provocation tests. Specific IgE antibodies to 
toluene diisocyanate: human serum albumin (HSA), diphenylmethane 
diisocyanate: HSA, and hexamethylene diisocyanate: HSA were 
measured in all patients by Phadebas RAST. Specific IgE to isocyanates 
is a more specific than sensitive index of occupational asthma and 
concluded that with a RAST score of 3 or more, it is wholly specific and 
therefore diagnostic of isocyanate-induced asthma 112. 
Several groups including Baur et al in 1984, Tee et al in 1998, Son 
M et al in 1998, have detected serum specific IgE antibodies to toluene 
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di-isocyanate - HSA conjugate in the sera of workers with a positive 
bronchial challenge to toluene di-isocyanate  113- 115. 
Tee et al reported that sensitivity of serum specific IgE to 
isocyanate was the highest when blood was taken less than 30 days after 
the last exposure. However, serum specific IgG to isocyanate may persist 
for several years after the last exposure to toluene di-isocyanate. 
Andre et al in 2005, in twenty-nine subjects demonstrated 
increased levels of specific IgE and/or IgG antibodies to isocyanates. 
Although increased levels of specific IgE and/or IgG antibodies have 
been documented in individual cases of occupational asthma caused by 
isocyanates, the frequency among workers with occupational asthma is 
still unknown. He concluded that the levels of specific IgG to isocyanates 
(hexamethylene di-isocyanate and diphenyl-methane di-isocyanate) bear 
a satisfactory association, in terms of sensitivity and specificity, 
suggesting that an immunologic mechanism is involved 116. 
Park HS, Kim HY et al in 2001, Park HS et al in 2002 and Ye YM 
et al in 2006 in different studies found that serum specific IgE and IgG 
antibodies to toluene di-isocyanate  human serum albumin conjugate 
were found to have diagnostic value 117- 119. 
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Raulf et al in 1998 and Wisnewski et al in 2006 in different studies 
found that other mechanisms, like cell mediated allergic reactions or 
pulmonary irritation are likely to be involved 120,6. 
Anjoeka et al in 2007, studied exposure- response relationships of 
respiratory symptoms and sensitization in population occupationally 
exposed to isocyanate oligomers during spray painting. Specific IgE and 
IgG to hexamethylene diisocyanate (hexamethylene di-isocyanate) were 
assessed in serum by Immuno CAP assay and enzyme immunoassays. 
Respiratory symptoms were more prevalent in exposed workers than 
among comparison office workers. Log–linear exposure–response 
associations were found for asthma like symptoms, chronic obstructive 
pulmonary disease–like symptoms, and work-related chest tightness. The 
prevalence of specific IgE sensitization was low, but IgE to oligomeric 
hexamethylene di-isocyanate – HSA was associated with exposure and 
work related chest tightness. The prevalence of specific IgG was higher 
and strongly associated with exposure 96. 
Aurelia et al in 2007 concluded that allergic sensitization mediated 
by IgE is the basis of allergic diseases and elevated total IgE proved to be 
a diagnostic criterion for allergic diseases inspite of well-known 
limitations 121. 
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Lushniak et al in 1998, Aul DJ et al in 1999 and Hur GY et al in 
2008 have measured diphenyl-methane di-isocyanate - specific antibodies 
by using enzyme linked immunosorbent assay (ELISA) 122- 124. 
Jagadeeshwar et al in 2012 found in their study that a total serum 
IgE level was considered to be higher in allergic subjects than in healthy 
subjects 125. 
ABSOLUTE EOSINOPHIL COUNT 
Eosinophilia is commonly encountered during routine 
investigation. However in the modern literature, only little work has been 
done in the field of blood eosinophilia. 
Wykoff et al in 1986 found that in developed countries that the 
most common etiology for eosinophilia is seasonal and perennial rhinitis, 
hay fever, asthma and allergic drug reaction 126. 
Enright et al in 1989 concluded that most asthmatics, especially 
those with intrinsic asthma have eosinophilia 127. 
Brigden et al in 1997 and Kobayashi et al concluded that allergy 
and atopy is described as the leading cause for eosinophilia in developed 
countries 128,129. 
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Leukens et al in 1972, Wardlaw et al in 1990 and Rothenberg et al 
in 1998, proposed different values of eosinophilia 130- 132. 
Marc.E.Rothenberg in 1998 classified eosinophilia into 
Mild: 351-1500/mm3 of blood. 
Moderate: 1500-5000/mm3 of blood. 
Severe: >5000/mm3 of blood. 
Bousquet et al in 2001 in a cross-sectional study showed that 
allergic rhinitis is strongly associated with asthma and BHR 133. 
“A Study of Clinical Profile and Spontaneous Course of 
Eosinophilia” by Anshu et al in 2002 found in their study that most of the 
eosinophilic patients were symptomatic 134. 
Usually patients of eosinophilia are asymptomatic as reported by 
Schulte et al in 2002 135.  
As said by Xu et al in 1997 and Brutsche et al in 2006 bronchial 
hyper reactivity is a risk factor for development of bronchial asthma 
136,137. 
 69 
In a study by Ajithkumar et al in 2013 study was done to find out 
the correlation and predictive value of absolute eosinophil count for 
bronchial hyperreactivity and revealed a relationship between peripheral 
blood eosinophilia and bronchial hyperreactivity in allergic rhinitis and a 
strong association between allergic rhinitis and lower airway 
dysfunction138. 
PHYSIOLOGY OF RESPIRATION 
Respiratory system comprises of lung, airways, muscles of thorax 
and abdomen, the integrated action of which is controlled by the 
respiratory centre in the central nervous system according to inputs from 
the receptors which monitor the various parameters related to the 
function. Lungs are the principle organs of respiratory system. 
Physiological anatomy 
Upper airways: 
Nose, sinuses, pharynx and larynx constitute the upper airways. 
Inspired air is humidified and conditioned by upper airways so that when 
it reaches lung it will be at body temperature. It helps to filter particles 
with size more than 10 micron in the inspired air. Respiratory epithelium 
of upper airways secretes immunoglobulin, inflammatory mediators, 
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interferons, which helps in host defence. Sinuses resonates the voice and 
lightens skull. Larynx is situated at the upper part of trachea and helps in 
sound production. 
Conducting airways: 
Conducting airway starts at trachea and include first 16 
generations, which includes bronchi, bronchioles and terminal 
bronchioles. Trachea divides into two main bronchi which in turn divide 
in a dichotomous or asymmetric pattern. This arrangement increases cross 
sectional area from 2.5 cm2 in trachea to 11800 cm2 in alveoli. Hence the 
velocity of airflow decreases in small airways 139. Conducting airways act 
as a conduit for airflow. It helps in body defence. Non ciliated cuboidal 
epithelial cells called Clara cells secrete defence markers like secretory 
immunoglobulin, collectins, defensins, peptidases, proteases, reactive 
oxygen and nitrogen species. 
Alveolar airways: 
Alveolar airway constitutes last 7 generations including respiratory 
bronchioles, alveolar ducts, and alveoli. The total area of the alveolar 
walls in contact with the capillaries in both lungs is about 70 m2. Alveoli 
 71 
are surrounded by pulmonary capillaries. Alveoli are lined by two types 
of cells; type I and II pneumocytes. Type II cells secrete surfactant.  
Thoracic cage: 
The ancients wondered about how air moved into and out of the 
lungs and as far back as Erasistratus the diaphragm was recognised to be 
involved in breathing. 
Galen was aware that the lungs fill the chest cavity, they are moved 
by the actions of the thorax and the large airways enlarge and lengthen 
during inspiration. Mayow, one of the oxford physiologists, drew heavily 
on the work of colleagues, such as Boyle and Hooke, to develop 
considerable insight into the mechanics of breathing. He also built the 
first model on record of the chest as a bellows, which contained a bladder 
within it 63. 
During the decade between 1915 and 1926, Rohrer and his 
colleagues provided a remarkably comprehensive synthesis of respiratory 
mechanics that included a description of the static pressure - volume 
characteristics of the respiratory system, the work of breathing. 
Interpretation of pulmonary function test requires an insight about the 
respiratory muscles and work of breathing. 
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The major muscles of respiration include the diaphragm, the 
external intercostals and the scalene which are all skeletal muscles. 
Skeletal muscles provide the driving force for ventilation; the force of 
contraction increases when they are stretched and decreases when they 
shorten. The force of contraction of respiratory muscles increases at 
larger lung volumes. 
The process of respiration or gas exchange begins with the act of 
inspiration, which is initiated by contraction of the diaphragm. The 
diaphragm is the major muscle of respiration and it divides the thoracic 
cavity from the abdominal cavity. On contraction, the diaphragm 
protrudes into the abdominal cavity and moves the abdomen outward to 
create negative pressure inside the chest. This increases the vertical 
dimension of the chest cavity and creates a pressure difference between 
the thorax and abdomen. 
During quiet breathing the diaphragm moves approximately 1 cm; 
however, during deep-breathing manoeuvres (vital capacity), the 
diaphragm can move as much as 10 cm. The diaphragm is innervated by 
the right and left phrenic nerves, which have their origins at the third to 
fifth cervical segments of the spinal cord. 
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The other important muscles of inspiration are the external 
intercostal muscles, which pull the ribs upward and forward during 
inspiration. This causes an increase in both the lateral and antero posterior 
diameter of the thorax. 
Innervation of the external intercostal muscles originates from 
intercostal nerves that arise from the same level of the spinal cord. 
Paralysis of these muscles has no significant effect on respiration because 
respiration is primarily dependent on the diaphragm. 
Accessory muscles of inspiration are the scalene muscles, which 
elevate the sternocleido mastoid and the alae nasi, which cause nasal 
flaring. However, they do contract vigorously during exercise, and when 
airway obstruction is significant, they actively pull up on the rib cage. 
During normal breathing they anchor the sternum and upper ribs. 
Because the upper airway must remain patent during inspiration, 
the pharyngeal wall muscles (genioglossus and arytenoid) are also 
considered to be muscles of inspiration. All of the rib cage muscles are 
voluntary muscles that are supplied by intercostal arteries and veins and 
innervated by motor and sensory intercostal nerves. 
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Exhalation during normal breathing is passive, but it becomes 
active during exercise and hyperventilation. The most important muscles 
of exhalation are those of the abdominal wall (rectus abdominis, internal 
and external oblique, and transversus abdominis) and the internal 
intercostal muscles, which oppose the external intercostal muscles (i.e., 
they pull the ribs downward and inward). The inspiratory muscles do the 
work of breathing. 
During normal breathing, work is low and the inspiratory muscles 
have significant reserve. Respiratory muscles can be trained to do more 
work, but there is a finite limit to the work that they can perform 32. 
PULMONARY FUNCTION TEST 
PFT are done to assess ventilation, diffusion, perfusion, and 
mechanics of respiration. The components of PFT include spirometry, 
measuring diffusing capacity and measurement of RV and TLC. 
Spirometry is the most important tool for assessing the functional status 
of the respiratory system. PFT helps in evaluation of dyspnoea, to 
differentiate obstructive and restrictive lung disease and in assessing 
degree of pulmonary impairment. 
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Indications of PFT: 
1. To investigate patients with suspected pulmonary disease. 
2. For assessing progress and response to treatment in patients with 
asthma, fibrosis and pulmonary vascular diseases. 
3. For pre operative evaluation before lung resection, abdominal and 
cardio thoracic surgeries. 
4. Evaluation of patients having risk of developing lung diseases like, 
exposure to radiation, medications, environmental and 
occupational hazards. 
5. Surveillance following lung transplantation to rule out rejection, 
infection and obliterative bronchiolitis 140. 
Indications of spirometry: 
Spirometry is a part of PFT, used to assess the ventilatory function 
of the lung. It’s a simple non invasive and easy to perform test, but 
requires substantial participation from the individual. 
Diagnostic: 
1. To measure the effects of disease on pulmonary function. 
2. To screen individuals at risk of having pulmonary disease. 
3. To assess pre operative risk 
4. To assess prognosis. 
 76 
5. To assess health status before beginning strenuous physical activity 
programme. 
Monitoring: 
1. To assess therapeutic interventions. 
2. To describe the course of disease that affect lung function 
3. To monitor people exposed to injurious agents. 
Disability/ impairment evaluation: 
1. To assesspatients as a part of rehabilitation programme. 
2. To assess risk as a part of insurance evaluation. 
3. To assess individuals for legal reasons. 
Public health: 
1. epidemiological surveys 
2. Clinical research. 
Contraindications of pulmonary function test: 
1. History of myocardial infarction within one month. 
2. Unstable angina. 
3. Recent thoraco abdominal surgeries. 
4. Recent ophthalmic surgery. 
5. Thoracic or abdominal aneurysm. 
6. Current pneumothorax. 
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7. Acutely ill patients and in patients with active infection PFT should 
be deferred 141.  
Factors affecting PFT: 
Pulmonary function test is influenced by various factors like age, 
sex, height, weight, body position, ethnicity, technical variations, 
socioeconomic status, genetic and environmental factors. 
Medications and hot beverages prior to test have a direct influence 
on the outcome of the test. Errors do occur with instrument, procedures, 
control values and calculations and standardisation minimises this type of 
errors. Calibration is the adjustment of the machine output and its validity 
reflects a known input. 
Physiological determinants of PFT include age, height, sex, 
ethnicity and body position 142. 
Age: 
Lung development occurs during the first two decades of life and 
matures by 20- 25 years and lung functions become steady later on. As 
age progresses, the lungs undergo structural, functional and 
immunological changes 143. 
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Estenne et al found out that decrease in compliance of chest wall 
and diaphragm- abdomen compartment with increasing age in 61 healthy 
adults aged between 24- 75 years. Respiratory muscle strength can be 
assessed by measuring maximal voluntary ventilation, maximum 
inspiratory pressure and trans diaphragmatic pressure 144. 
Enright and co workers showed the decrease in maximum 
inspiratory pressure in elderly people aged between 65- 85 years and this 
decrease was more in men145. Tolep et al showed decline in respiratory 
muscle strength with advancing age 146. 
Mc Claran and co- workers, demonstrated that there was a decline 
in maximum voluntary ventilation in elderly individuals 147. 
Changes in lung parenchyma and peripheral airways with age were 
studied in senescence accelerated mice. Teramoto et al 148 and kurozumi 
et al 149 conducted two different studies and found out in senescence 
accelerated mice that enlargement of alveolar duct size was seen with 
advancing age. Distension of alveolar spaces and increase in lung 
volumes were explained by decrease in elastic fibres of lung resulting in 
distension of alveolar spaces. 
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Verbeken et al by morphometric technique studied excised human 
lung after autopsy which showed increased thickening of alveolar septa 
and isolated airspace enlargement but there was no destruction of alveolar 
walls or signs of inflammation 150. 
Gillooly and Lamb also found out increased airspace size in 
autopsy specimens151. Niewoehner et al by autopsy studies assessed the 
mean bronchiolar diameter and found that the diameter decreased after 
age of 40. This finding along with decrease in supporting tissues around 
the airways may contribute to decline in expiratory flow noted with 
aging152. 
Increased residual volume of about 50% is seen between 20- 70 
years. This may be due to loss of elastic recoil of lung parenchyma and 
decrease in respiratory muscle strength. Increased stiffness of chest wall 
results in progressive decrease in vital capacity. 
Total lung capacity remains almost constant throughout life. 
Functional Residual Capacity increases as age advances because of 
increased elastic recoil of chest wall and decreased elastic recoil of lung 
parenchyma. 
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Forced Expiratory Volume increase with age group upto 18 years 
and then starts to decline. FEV1 and FVC show no change between 18- 25 
years of age and then start to decline 153. Some studies prove that this 
decrease in these parameters was found to be linear 154- 156 . 
According to Dockery et al and burrows et al, decrease in these 
parameters was non- linear. Decline in FEV1 starting from 35- 40 years is 
25- 30 ml/ year and rate of decline doubles after 70 years of age 157. A 
study by Schimdt and colleagues showed that FEV1/ FVC values remain 
stable in young adults. FEV1/ FVC values decrease in females above 55 
years and in males above 60 years 158. 
Fowler et al studied 136 subjects above 60 years and found out 
decrease in Peak Expiratory Flow Rate which is due to loss of elastic 
recoil of lung, changes in peripheral airways and due to loss of supporting 
tissue around the airways 159. 
Height: 
ATS recommends that height measurement of subject undergoing 
PFT should be done with stadiometer using standard technique. Lung 
volumes are dependent on the body size and height of the individual such 
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that same height males have larger lung function values when compared 
to females and Whites have greater values compared to Blacks. 
It was Hutchinson who first correlated vital capacity with standing 
body height. Kelly in 1993 found out the relationship between vital 
capacity and with third power of height. In 1950 Bateman found out 
relation of cube of height of adults with average status with total lung 
capacity and its sub divisions 160. 
During growth spurt standing height increases and lung growth 
lags behind. So there occurs a change in relationship between these two 
during adolescence. 
Weight: 
Shoenberg et al in 1978 and Chen et al in 1993 studied flow 
volume curves of 7123 men and studied their relation with age, weight 
and standing height. They noticed an initial increase in lung function with 
increasing weight and it was explained to be due to increase in muscle 
force. But as weight increased further lung function decreased. This was 
due to limitation of mobility of thoracic cage due to obesity 161,162. 
Bande et al in 1980 found out a decline in FVC and FEV1 with 
weight gain163. Dontas studied FVC and FEV75% of 592 men aged 25- 74 
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years in 1960, 1965 and in 1970 and found increase in body weight 
intensified the age dependent loss of FVC and FEV75% 164. 
Nemery in 1983 conducted a cross sectional study in steel workers 
aged 45- 55 years. Study included both smokers and non- smokers. The 
study showed significant positive correlation in smokers only 165. Ray 
studied the effect of obesity on respiratory function in 43 massive obese, 
non smoking young adults. This study showed no significant relation 166. 
Thomas in 1989 studied 29 morbidly obese subjects before and 
after weight reduction surgery. Loss of weight in these subjects was 
associated with improvement in lung function167. Chen found out that 
weight gain was more prominent predictor of decline in pulmonary 
function. 
In men significant relations were observed in FVC, FEV1 and 
FEF25- 75% and in females relations were observed in FVC and FEV1. It 
was found that 1 kg increase in weight was associated with an excess loss 
of 26 ml in FVC in males and 14 ml in females. In FEV1 a drop of 23 ml 
was seen in men and 9 ml in females 162. 
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Gender: 
Lung volumes and capacities of males and females of same age, 
height and weight are different. Mead and Thurlbeck revealed larger 
diameter airways, larger lung volumes and larger diffusion surfaces in 
males. 
In females, fewer number of alveoli and smaller airway diameter 
relative to lung size result in lower diffusion capacity168,169. There was no 
sex difference in the elastic properties of lung, chest wall and 
compliance170. 
Ethnicity: 
Many studies prove differences in lung function values but the 
reason for these variations were not clearly understood. In 1983 His 
studied 1800 normal children of Black, White and Mexico American 
ethnic groups of age between 7- 20 years. They found out that using 
sitting height as predictor decreased racial difference among the study 
groups 171. In 1984 Myers considered role of social class status on ethnic 
variation of lung function in South African Blacks. Their lung function 
values were compared with their normal predicted values and found out 
that predicted values suggested for them were higher 172. He explained 
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this disparity in terms of confounding effect of social status. Donelly et al 
studied Caucasians, Chinese and Indians and found out that TLC, FVC 
and FEV1. TLC was 15- 22% lower in Indians and Chinese when 
compared with that of Caucasians. Shape of chest wall appeared to be an 
important determinant of TLC. Caucasians have wider chest wall. They 
suggested that difference in lung volumes were not due to alveolar 
distension or inspiratory muscle pressure but due to difference in number 
of alveoli which in turn depends on chest shape 173. 
In 2001 Hrik khan suggested roles of racial differences in upper 
and lower body segments ratio and socio economic status 174. Whittaker 
and et al tested the hypothesis that ethical variations were due to 
difference in chest size. They found out that height was a predictor of 
lung function, but taking sitting height instead of standing height does not 
show any difference. Chest size was a predictor for FVC and FEV1 and 
chest height was the best predictor of PEFR. FEF25- 75% does not depend 
on chest dimensions 175. 
Body Position: 
While performing PFT patient can adopt sitting standing position. 
But sitting posture was preferred during the manoeuvre because of safety 
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reasons as some procedures can cause fall due to syncope. In normal 
weight individuals the sitting and standing values are typically equivalent. 
But in obese individuals, standing posture is preferred. They can 
make deep inspiration in standing position. Change from standing to the 
supine position decrease VC, FRC and TLC. This can be explained by 
upward shift of diaphragm, change in chest wall dimension and increase 
in thoracic blood volume 176. 
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AIM AND OBJECTIVES 
AIM 
To evaluate the changes in dynamic respiratory functions of spray 
painters. 
OBJECTIVES 
1. To measure dynamic respiratory functions in spray painters using 
Easyone Diagnostic Spirometer.  
2. To measure serum of immunoglobulin E (IgE) level  
3.  To calculate absolute eosinophil count. 
4.  To compare parameters of study group with that of control group. 
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MATERIALS AND METHODS 
Sample size:  
30 
Study design:  
Cross sectional study 
Study population:  
Spray painters of age group 25 to 50 years. 
Study duration:  
From July – October 2014. 
Ethical considerations:  
Institutional ethical committee approval was obtained. 
Parameters compared: 
1. In PFT, 
I. Forced Vital Capacity (FVC) in (lit) 
II. Forced Expiratory Volume in 1st second (FEV1) as (%) 
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III. FEV1/FVC 
IV. Mean Forced Expiratory Flow (FEF 25-75%) as (lit/sec) 
V. Peak Expiratory Flow Rate (PEFR) as (lit/min) and 
VI. Maximum Voluntary Ventilation (MVV) as (lit/min). 
2. Level of IgE and  
3. Absolute eosinophil count. 
Inclusion criteria: 
1. Spray painters of age group 25- 50 years, who are involved in 
spray painting for duration more than 2 years. 
2. Controls not exposed to spray painting of age group 25- 50 years 
from Master health check- up clinic  at Stanley Medical College. 
Exclusion criteria: 
1. Asthmatics 
2. History suggestive of worm infestations 
3. Chronic allergic manifestations 
4. Tuberculosis 
5. Systemic illness like diabetes, hypertension 
6. Renal and hepatic insufficiency 
7. Smokers 
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8. Alcoholics 
9. Other lung diseases. 
Pre- requisites: 
 The subjects were instructed to have light breakfast. 
 The subjects were instructed to avoid beverages before recording PFT. 
 The subjects were made to get accustomed to research laboratory. 
 The research room was made calm and comfortable to the subjects. 
 The procedure was explained in their own language. 
 The explanation and demonstration of the procedure was done. 
 The subjects were properly instructed and motivated. 
Methodology: 
After obtaining informed written consent from the subjects in their 
own language, pulmonary function test was recorded in research lab, 
Department of Physiology, Stanley Medical College using Easyone 
diagnostic spirometer. Pre-structured proforma based on Occupational 
Safety and Health Adminstration (OSHA) Respirator Medical Evaluation 
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Questionnaire containing name, age, gender, height in cms, weight in kgs 
and duration of exposure of the subjects, medical history and 
occupational history was recorded. 
The entire procedure was explained and later demonstrated to the 
subjects satisfactorily before recording PFT, as spirometry test requires 
active participation by the subjects. PFT was recorded in the upright 
sitting posture in the morning using the Easy one Diagnostic Spirometer.  
Forced Vital Capacity (FVC): 
After choosing PERFORM TEST in the main menu we should 
choose NEW and confirm by pressing ENTER. The instrument will then 
allow us to enter the study subject’s data. After entering the patient data, 
we move on to the TEST SELECTION menu. Then we choose the FVC 
test and confirm with ENTER. A spirette is inserted into the instrument 
such that the arrow on the spirette is lined up with the arrow on the 
instrument. When the patient is ready, we should press ENTER so that we 
hear the sensor buzzing. Now the instrument sets baseline and during this 
phase we have to avoid air flow into the spirette. Blocking one end of the 
spirette ensures that the baseline is set precisely. When the baseline has 
been set, an audible signal will sound followed by BLAST OUT on the 
display. Now the subject is asked to breathe in deeply and the spirette is 
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inserted correctly into the mouth such that no air leaks out. Now the 
subject is asked to exhale as firmly and as quickly as possible, and 
continue exhaling until all air has been exhaled and then followed by a 
deep maximum inhalation. At least three acceptable and reproducible 
maneuvers should be performed and the session is complete when the 
display shows SESSION COMPLETE177. 
Other parameters Forced Expiratory Volume in 1st second (FEV1), 
FEV1/ FVC ratio, Mean Forced Expiratory Flow (FEF25-75%) and Peak 
Expiratory Flow Rate (PEFR) was calculated and data is provided by the 
Easyone diagnostic spirometer. 
Maximum Voluntary Ventilation (MVV): 
After meeting all above said pre requisites, the subject inserts the 
spirette into their mouth and fully inhales and exhales for an 
uninterrupted period of at least 12 seconds. This measures the maximum 
voluntary ventilation. 
Interpretation of pulmonary function test parameters was done 
based on GOLD/ Hardie interpretation.  
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After recording PFT, blood sample was collected from the subjects 
under strict sterile aseptic precautions. Using disposable syringes 5 ml of 
blood was removed which was immediately replaced into red tube for IgE 
measurement and lavender tube with EDTA for Absolute Eosinophil 
Count which was sent to Dr.Ganesan’s Hitech Diagnostic Centre PVT 
Ltd, Chennai for laboratory procedure. Picture 7, 8 & 9. 
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PICTURE – 7 : GOLD/HARDIE INTERPRETATION OF PFT. 
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PICTURE – 9 : REPORT OF PFT   
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PICTURE – 8 : RECORDING OF PFT - NEURO PHYSIOLOGY 
LAB PHYSIOLOGY DEPARTMENT, STANLEY MEDICAL 
COLLEGE 
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STATISTICAL ANALYSIS 
Data collected was stored and analyzed statistically by unpaired 
student t test using SPSS version 17.0. The Data is expressed as mean ± 
standard deviation. Statistical significance was tested using p value. 
 p value < 0.050- Significant. 
 p value < 0.010 - Highly significant.  
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RESULTS 
In this present study, pulmonary function test was recorded in 30 
individuals exposed to spray painting and the parameters studied were 
FVC, FEV1, FEV1/ FVC, FEF25- 75%, PEFR and MVV. Along with this, 
measurement of IgE and Absolute Eosinophil Count (AEC) was done and 
compared with that of age matched 30 individuals not exposed to spray 
painting. 
The data are expressed as Mean ± Standard deviation and p value < 
0.05 is taken as significant. 
The baseline characteristics of the study group and control group 
are shown in table 4. Of the total 30 subjects in study group, the mean age 
in years is 45 ± 4, mean height in centimetres is 158 ± 8, mean weight in 
kilograms is 73 ± 12 and mean BMI is 29 ± 4 and that of 30 subjects in 
control group the mean age in years is 44 ± 4, mean height in centimetres 
is 159 ± 6, mean weight in kilograms is 71 ± 10 and mean BMI is 28 ± 4.  
From table 5, it is observed that there is a highly significant change 
in FVC (2.40 ± 0.31), FEV1 (2.16 ± 0.26) and significant change in FEV1/ 
FVC (0.90 ± 0.08) among study group when compared to that of control 
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group FVC (3.29 ± 0.27), FEV1 (3.11 ± 0.28) and FEV1/ FVC (0.95 ± 
0.04). 
From table 6, it is observed that there is a highly significant change 
in PEF (4.80 ± 1.74) and MEF25- 75% (3.01 ± 1.07) among study group 
when compared to that of control group PEF (6.46 ± 1.91) and MEF25- 75% 
(4.47 ± 0.82). 
From table 7, it is observed that there is a highly significant change 
in MVV (82.35 ± 20.07) among study group when compared to that of 
control group MVV (102.56 ± 25.15). 
From table 8, it is observed that IgE (410 ± 20) and AEC (333 ± 
22) are significantly increased in study group when compared to that of 
control group IgE (97 ± 41) and AEC (228 ± 90). 
In table 9, duration of exposure to spray painting and pulmonary 
function test has been correlated and found that there is a significant 
correlation existed between MEF25- 75% and duration of exposure. No 
significant correlation demonstrated between FVC, FEV1, FEV1/ FVC, 
PEF and MVV and duration of spray paint exposure. 
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In table 10, duration to exposure to spray painting and IgE levels 
and AEC was correlated and found that there was no significant 
correlation between the two parameters. 
While correlating IgE levels and parameters of pulmonary function 
test in table 11, we found that the correlation was not significant. 
While correlating AEC and parameters of pulmonary function test 
in table 12, we found that the correlation was not significant. 
  
 103 
 
TABLES AND CHARTS 
Table 4: Comparison of basic parameters of control and study 
group: 
Parameters 
studied 
Control group 
n= 30 
Mean ± SD 
Study group 
n= 30 
Mean ± SD p value 
Age  (years) 44 ± 4 45 ± 4 0.152 
Height (cms) 159 ± 6 158 ± 8 0.410 
Weight (kgs) 71 ± 10 73 ± 12 0.608 
BMI 28 ± 4 29 ± 4 0.303 
 
**p value ≤ 0.001 is highly significant 
*p value ≤ 0.05 is significant 
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Chart 1: Comparison of basic parameters of control and study 
group: 
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Table 5: Comparison of FVC, FEV1 and FEV1/ FVC among control 
and study group: 
Parameters 
studied 
Control group 
n= 30 
Mean ± SD 
Study group 
n= 30 
Mean ± SD p value 
FVC(L) 3.29 ± 0.27 2.40 ± 0.31 0.001** 
FEV1(L) 3.11 ± 0.28 2.16 ± 0.26 0.001** 
FEV1/ FVC 0.95 ± 0.04 0.90 ± 0.08 0.011* 
 
**p value ≤ 0.001 is highly significant 
*p value ≤ 0.05 is significant 
  
 106 
 
 
Chart 2: Comparison of FVC, FEV1 and FEV1/ FVC among control 
and study group: 
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Table 6: Comparison of PEF and MEF25- 75%, among control and 
study group: 
Parameters 
studied 
Control group 
n= 30 
Mean ± SD 
Study Group 
n= 30 
Mean ± SD p value 
PEF(L/S) 6.46 ± 1.91 4.80 ± 1.74 0.001** 
MEF25-75%(L/S) 4.47 ± 0.82 3.01 ± 1.07 0.001** 
** p value ≤ 0.001 is highly significant 
*p value ≤ 0.05 is significant 
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Chart 3: Comparison of PEF and MEF25- 75% among control and 
study group: 
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Table 7: Comparison of MVV among control and study group: 
Parameters 
studied 
Control group 
n= 30 
Mean ± SD 
Study Group 
n= 30 
Mean ± SD p value 
MVV(L/M) 102.56 ± 25.15 82.35 ± 20.07 0.001** 
 
**p value ≤ 0.001 is highly significant 
*p value ≤ 0.05 is significant 
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Chart 4: Comparison of MVV among control and study group: 
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Table 8: Comparison of IgE and AEC among control and study 
group: 
Parameters 
studied 
Control group 
n= 30 
Mean ± SD 
Study Group 
n= 30 
Mean ± SD p value 
IgE(IU/ML) 97 ± 41 410 ± 20 0.001** 
AEC(Cells/Cmm) 228 + 90 333 + 22 0.017* 
**p value ≤ 0.001 is highly significant 
*p value ≤ 0.05 is significant 
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Chart 5: Comparison of IgE and AEC among control and study 
group: 
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Table 9: Correlation between duration of spray paint exposure and 
pulmonary function test parameters in study group: 
Duration 
of spray 
paint 
exposure 
Parameters studied 
Pearson 
Correlation FVC FEV1 
FEV1/ 
FVC PEF 
MEF 
25-75% 
MVV 
r Value -0.08 -0.29 -0.25 -0.19 -0.42* -0.16 
p value 0.67 0.12 0.18 0.31 0.02* 0.39 
* p value ≤ 0.05 is significant. 
Significant p value- 0.02* 
 Statistically significant correlation existed between MEF25- 75% and 
duration of exposure. 
 No statistically significant correlation demonstrated between FVC, 
FEV1, FEV1/ FVC, PEF and MVV and duration of spray paint exposure. 
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Table 10: Correlation between duration of spray paint exposure and 
IgE level and AEC in study group: 
Duration of spray 
paint exposure 
Pearson Correlation IgE AEC 
r Value -0.26 -0.26 
P value 0.16 0.16 
* p value ≤ 0.05 is significant. 
No statistically significant correlation between duration of spray 
paint exposure and IgE levels and AEC. 
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Table 11: Correlation between IgE and pulmonary function test 
parameters in study group: 
IgE 
Parameters studied 
Pearson 
Correlation FVC FEV1 
FEV1/ 
FVC PEF 
MEF 
25-75% MVV 
r Value -0.04 -0.30 -0.29 -0.31 -0.27 0.01 
p value 0.84 0.11 0.11 0.10 0.15 0.98 
* p value ≤ 0.05 is significant. 
No statistically significant correlation between IgE levels and 
pulmonary function test parameters. 
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Table 12: Correlation between AEC and pulmonary function test 
parameters in study group: 
AEC 
Parameters studied 
Pearson 
Correlation FVC FEV1 
FEV1/ 
FVC PEF 
MEF 
25-75% 
MVV 
r Value 0.01 0.01 -0.04 -0.05 -0.10 -0.25 
P value 0.94 0.97 0.829 0.78 0.60 0.18 
* p value ≤ 0.05 is significant. 
No statistically significant correlation between AEC and 
pulmonary function test parameters. 
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DISCUSSION 
Measurement of pulmonary function tests in individuals exposed to 
spray painting has proven to be an important diagnostic tool. Di-
isocyanates are among the most common causes of occupational asthma3. 
Di-isocyanates cause asthma by inducing intense airway inflammation 
and cause a major health effect. It also causes accelerated decline in lung 
function6. 
Overall 5 to 30 percent of workers exposed to toluene di-
isocyanate develop airway symptoms. One study which examined the 
decremental fall in flow rates in workers exposed to toluene di-isocyanate 
predicted a 2 Litre greater loss in FEV1 in these workers when compared 
with controls 90. 
Musk et al reviewed the known respiratory effects of isocyanates 
and showed good evidence that isocyanates can cause chemical 
bronchitis/ pneumonitis and capabale of causing isocyanate asthma and 
other non specific airway disease 109. 
In this study we compared the respiratory function test parameters 
of study and control group. The respiratory parameters compared were 
FVC, FEV1, FEV1/ FVC, PEFR, FEF 25-75% and MVV. Along with this we 
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also compared the IgE levels and AEC among the study and control 
group. 
On comparing the demographic profile of these individuals, age 
matched, BMI matched individuals were included in this study. The mean 
age was 45 years with standard deviation ranging from 41 to 49 years in 
study group and the mean age was 44 years with standard deviation 
ranging from 40 to 48 years in control group. According to a study 
conducted by Gupta et al, he suggested that there was a significant age 
related senile asthma occurring after 50 years in Indian population 178. 
Hence in our study we excluded spray painters who are more than 50 
years in order to rule out bias due to age related respiratory changes. 
The mean height was 158 cms with standard deviation ranging 
from 150 to 166 cms in study group and the mean height was 159 cms 
with standard deviation ranging from 153 to 165 cms in control group 
showing not a much difference, because vital capacity has a correlation 
with regard to height as studied by Bateman et al160. 
The mean weight was 73 kilograms with standard deviation 
ranging from 61 to 85 kilograms in study group and the mean weight was 
71 kilograms with standard deviation ranging from 61 to 81 kilograms in 
control group with not a much difference among study and control group 
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since increased weight and obesity has a direct effect on lung function 
due to decreased mobility of thoracic cage as stated by Shoenberg et al161. 
FVC, FEV1 and FEV1/ FVC are better indicators to differentiate 
obstructive or restrictive lung disease. Isocyanate exposure in spray paint 
produce occupational asthma which causes an obstructive type of lung 
disease substantiated by normal or decrease in FVC, decrease in FEV1 
and decrease in FEV1/ FVC ratio. 
Pronk et al, found a strong positive association between isocyante 
exposure and bronchial hyperresponse which is detected by significant 
change in FEV1/ FVC ratio. In our study too we found that there is 
significant decrease in FVC, FEV1 and FEV1/ FVC ratio concurring with 
the findings of Pronk et al and Wegman et al96,109. This significant 
decrease in lung parameters was due to isocyanate induce chemical 
bronchitis which serve as a potent pulmonary sensitizer causing non 
specific airway disease and asthma. 
Siddanagoudra et al while studying respiratory morbidity in spray 
paint workers in an automobile sector, found that, of the 70 car paint 
workers included in this study, nine isocyanate-exposed workers showed 
a significant reduction in FEV1/ FVC suggestive of obstructive lung 
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pattern and a strong correlation between duration of exposure and 
pulmonary functions 179. 
Peak expiratory flow rate is a better indicator of larger central 
airway disease, and helps to assess the severity of an asthma attack and to 
assess the response to treatment during an acute attack. 
In our study we found that there is a significant decline in PEFR in 
study group when compared to control group indicating a larger airway 
involvement due to spray paint. Randolph et al studied PEFR in 21 
subjects and did serial measurements of PEFR for 30 days and he 
concluded that PEFR is an insufficient sensitive indicator 82. 
Burge et al concurs with these results showing that PEFR are 
proportionally less than FEV in the same individual and concluded that 
linear calibration of peak flow meters is needed80.    
FEF25-75% is a better indicator of smaller airway disease. Randolph 
et al, concluded that even though FEV1 helps to predict OA, he has 
suggested that FEF25-75% seems to be a better predictor of small airway 
disease. In our study too we found that there is a statistically significant 
change in FEF25- 75% concurring with Randolph et al82. 
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While correlating duration of spray paint exposure and respiratory 
compromise in our study, there was a strong negative correlation between 
FEF25-75% indicating smaller airway involvement as duration increases 
concurring with Mandal et al where he found a strong negative 
correlation between pulmonary functions and duration of exposure to 
solvents and dust104. 
Chattopadhyay et al in his 2.5 years follow-up study observed that 
pulmonary function parameters of isocyanate exposed workers for long 
duration were reduced even in very low concentration 98 concurring with 
findings of Mandal et al104. 
MVV is more a sensitive indicator of airflow obstruction and in our 
study too shows a significant decrease in MVV when compared to control 
group emphasising the fact that obstructive airway disease is seen in 
isocyanate induced asthma. 
IgE levels were significantly elevated in our study group exposed 
to spray painting in agreement with Pezzini et al were he found that a 
specific IgE-mediated response in twenty-eight workers exposed to 
toluene di-isocyanate or diphenyl-methane di-isocyanate. The results 
suggest an association between the presence of specific IgE, early 
asthmatic symptoms and heavy episodic exposure107. 
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AEC is significantly elevated in study group showing a strong 
relationship between isocyante exposure and allergic reactions concurring 
with Jagadeeshwar et al125 and Agha et al111. 
Correlation between duration of exposure to spray paint and IgE 
level and AEC in study group showed weak negative correlation, which 
was not significant statistically. This is due to the reason that the 
individual gets conditioned to the allergic aspect as the duration of spray 
paint exposure prolongs. This concurred with Tee et al, where in his study 
he reported that specific IgE to isocyanate was higher when blood was 
taken less than 30 days after last exposure114. 
Correlation between IgE and AEC and pulmonary function test 
parameters in study group showed weak negative correlation but not 
statistically significant. This outcome  of  the study concurred with Chan 
et al where he found that, continuous exposure to isocyanate in sensitised 
individuals led to deterioration in lung function and increase in non- 
specific bronchial reactivity68. 
Thus from above studies, we observe that isocycrates in spray paint 
produce a marked respiratory compromise leading to occupational 
asthma. This can be detected by measuring pulmonary function test in 
individuals working with spray paint. Measuring IgE along with 
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pulmonary function test serves as a sensitive indicator if done early 
during the period of exposure. 
Also measuring Absolute Eosinophil Count along with PFT and 
IgE serves as a strong evidence for allergic component involvement and 
bronchial hyperreactivity. Our study too supports the above finding and 
hence from our study we conclude that pulmonary function test done 
along with IgE and AEC measurement can be used as an early 
investigatory tool to bring down the morbidity. 
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SUMMARY 
Occupational health hazards and health problems lay unaware in 
developing nations when compared to developed countries. 
Changes in pulmonary function test in workers in spray painting 
and measurement of IgE and AEC in them proves a strong association 
between development of bronchial hyperreactivity and asthma. 
Periodic inspection of working environment provides information 
and helps in anticipation of occupational disabilities. Work place 
environment should be designed according to norms suggested so that is 
does not affect the health of workers. 
The correct use of protective devices like masks and gloves should 
be explained. They should be frequently health educated using charts, 
posters and hand bills. 
Periodical medical check-up of workers is very necessary when 
they handle toxic or poisonous substances. 
Pre placement examination is the foundation of an efficient 
occupational health service. Pre placement examination will also serve as 
a useful bench mark for future comparison. 
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CONCLUSION 
Thus on evaluating the changes in dynamic respiratory functions of 
spray painters, we conclude that there is a significant decrease in FVC, 
FEV1, FEV1/ FVC, PEFR, MEF25- 75% and MVV and significant increase 
in serum IgE levels and AEC in study group establishing a strong 
evidence for respiratory impairment due to isocyanates. 
It is a fact that better investigatory tools for early recognition of 
occupational asthma can lead to early preventive strategies and provide 
means for improving the medical management of patients. 
Prevention of isocyanate induced occupational asthma is the need 
of the hour and effective management is removal from the offending 
environment. 
Prophylactic use of respirators in areas with high concentrations of 
isocyanates is essential to prevent the development of asthma. 
The other protective devices comprise ear plugs, helmets, safety 
shoes, aprons, gloves, gum boots, barrier creams, screens and goggles. 
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In future pulmonary function test, IgE and AEC estimations may 
be a sensitive means to correlate isocyanate exposure and respiratory 
disease. 
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ANNEXURE – I 
 
PROFORMA 
 
1. Serial Number: 
2. Name: 
3. Age: 
4. Sex: 
5. ID Number: 
6. OP/IP Number: 
a. Personal history: 
b. Type of food habits: veg /non veg /mixed 
c. Type of house: kutcha /pucca /semi 
d. Religion: Hindu /Muslim /Christian /others 
e. Occupation:                                  Duration: 
f. Per capita income: No. of  family members:            
                                     Net family income: 
g. Education qualification: nil education /class I-V /class VI-XII /college 
/professional 
h. Social habits: Smoking: active /passive 
                             Betel nut/leaf chewing: +/- 
i. Socio economic status: Skilled/ Semi skilled with fixed wages/ Semi skilled 
with daily wages 
7. Martial history: Married/Unmarried 
8. Clinical history: 
Height:                                     Weight:         Chest expansion: 
 150 
Pulse rate:                                 BP:                       Respiratory rate: 
9. History suggestive of bronchial asthma: inhalers/ iv drugs/ constant 
 nebulisation 
10. History suggestive of tuberculosis: 
11. History suggestive of worm infestations: abdominal discomfort/ altered bowel 
 habits/   
12. Investigations: 
 PFT: 
 IgE LEVEL: 
ABSOLUTE ESINOPHIL COUNT:   
  
 151 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 152 
 
 
 
 
  
 153 
 
 
 
 
 
 
 
 
 
 
MASTER SHEET 
 
 154 
MASTER SHEET SHOWING OBSERVED VALUES 
 
 
Id 
Controls Age Sex Ht(cm) Wt(kg) BMI Duration FVC(L) FEV1 (L) 
FEV1/  
FVC  PEF (L/s) 
MEF25-75 
(L/s) 
MVV 
(L/m) 
IgE 
(IU/ml) 
AEC 
(cells/cmm) 
505 45 m 160 60 23.4  - 3.38 3.19 0.95 7.31 4.96 130.6 94.6 210 
508 49 m 156 75 30.8  - 3.05 2.89 0.88 5.11 3.72 124.7 64.5 250 
525 45 m 162 65 24.8  - 3.19 3.01 0.94 5.52 4.09 107.6 84.1 300 
526 38 m 168 80 28.3  - 3.31 2.88 0.84 3.66 3.01 70 67.5 170 
527 46 m 161 70 27  - 3.31 2.91 0.81 4.02 3.67 65.7 104.1 300 
529 47 m 161 66 25.5  - 3.46 3.08 0.89 7.53 3.84 81.4 143 100 
531 46 m 159 62 24.5  - 3.29 3.17 0.96 4.53 4.11 99.6 31.73 120 
533 46 m 159 75 29.7  - 3.34 3.05 0.91 8.52 4.77 115.3 106.8 170 
534 42 m 168 75 26.6  - 3.11 3.04 0.98 8.52 5.76 144.8 128.6 280 
535 46 m 161 74 28.5  - 3.19 2.95 0.85 8.34 3.85 88.5 134.5 270 
538 40 m 153 76 32.5  - 3.32 3.19 0.93 5.29 4.37 81.7 166.5 460 
539 45 m 162 71 27.1  - 3.16 3.15 1 4.94 3.95 78.5 143.8 250 
540 50 m 167 74 26.5  - 3.11 3.01 0.97 8.3 5 87.2 58 160 
541 45 m 150 68 30.2  - 3.11 3.04 0.98 8.52 5.76 144.8 97.2 260 
542 39 m 154 67 28.3  - 3.02 2.99 0.99 6.65 5.04 91.5 35.9 180 
543 38 m 165 92 33.8  - 3.48 3.23 0.93 4.24 3.95 114.4 58 260 
544 47 m 157 65 26.4  - 3.98 3.64 0.91 8.83 5.53 143.1 110.5 350 
546 38 m 168 75 26.6  - 3.16 3.15 1 4.94 3.95 78.5 126.5 110 
547 47 m 145 47 22.4  - 3.17 3.17 1 4.97 3.94 88.5 85.2 200 
548 47 m 172 86 29.1  - 3.11 2.87 0.92 6.25 4.32 104.9 36.2 120 
549 38 m 161 86 33.2  - 3.98 3.64 0.91 8.83 5.53 143.1 27.37 260 
550 38 m 162 79 30.1  - 3.48 3.47 1 9.48 5.99 126.5 68.7 130 
551 47 m 162 67 25.5  - 3.16 2.81 0.89 4.02 3.23 116.3 126.5 110 
552 40 m 164 66 24.5  - 3.11 3.01 0.97 8.3 5.17 88.2 171.6 180 
557 38 m 152 66 28.6  - 3.04 2.91 0.96 3.78 3.47 77.3 47.99 220 
558 48 m 156 71 29.2  - 3.11 3.01 0.97 8.5 5.11 97.2 106.8 420 
559 43 m 157 51 20.7  - 3.18 3.17 1 5.63 4.67 85.8 142.8 260 
560 47 m 149 90 40.5  - 3.16 3.15 1 4.94 3.95 78.5 121.7 170 
561 48 m 155 74 30.8  - 3.98 3.64 0.91 8.83 5.53 143.1 140 330 
562 47 m 157 65 26.4  - 3.22 2.85 0.88 5.57 3.88 79.6 76.8 240 
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Id Study 
Group Age Sex Ht(cm) Wt(kg) BMI Duration FVC(L) 
FEV1 
(L) 
FEV1/  
FVC  PEF (L/s) 
MEF25-75 
(L/s) 
MVV 
(L/m) 
IgE 
(IU/ml) 
AEC 
(cells/cmm) 
501 49 m 180 73 22.5 7 2.96 2.09 0.71 2.63 1.85 103.3 524.12 290 
502 50 m 160 85 33.2 7 2.37 2.07 0.87 4.58 2.52 67 539.6 220 
506 45 m 159 82 32.4 12 2.15 2.11 0.98 6.55 4.14 83.1 305.61 540 
507 49 m 156 65 26.7 10 2.47 2.4 0.97 6.43 3.34 79.8 199.63 600 
509 50 m 144 40 19.3 8 1.81 1.8 0.99 5.26 2.92 70.8 660.91 140 
510 50 m 147 65 30.1 12 2.32 2.03 0.87 5.02 2.7 80.5 318.14 600 
511 49 m 155 62 25.8 12 2.1 1.83 0.87 4.08 2.14 84 2500 410 
512 48 m 157 62 25.2 14 2.87 2.01 0.7 3.48 1.61 121 622.92 290 
513 44 m 154 77 32.5 7 2.19 2.03 0.93 2.73 2.53 87 501.8 340 
514 49 m 156 75 30.8 7 2.19 2.14 0.98 5.21 4.21 72.2 362.6 100 
515 44 m 165 64 23.5 15 2.08 1.99 0.96 3.92 2.95 38.1 217.3 210 
516 37 m 161 80 30.9 4 2.75 2.68 0.97 6.16 4.58 123.4 440.81 110 
517 44 m 165 65 23.9 17 2.22 2.07 0.93 2.6 2.28 65.1 248.5 170 
518 40 m 161 78 30.1 3 2.8 2.49 0.89 4.91 3.68 88.1 464.9 130 
519 44 m 165 80 29.4 18 2.77 2.12 0.77 5.83 1.76 80.1 403.8 310 
520 39 m 148 69 31.5 19 2.68 2.43 0.91 5.46 2.74 115 368.86 100 
521 50 m 154 65 27.4 12 2.89 2.29 0.79 3.23 2.06 54.2 403.8 310 
522 50 m 159 95 37.6 10 2.19 2.16 0.99 6.69 5.75 96.6 562.6 100 
523 49 m 154 68 28.7 15 2.13 1.91 0.9 2.72 1.93 81.3 201.8 340 
524 44 m 167 85 30.5 12 2.56 2.52 0.98 4.85 4.27 82 251.6 580 
528 50 m 148 64 29.2 17 2.26 1.85 0.82 1.99 1.53 49.6 367.5 870 
530 50 m 148 74 33.8 6 2.18 2.02 0.92 5.9 3.12 88.1 431.73 120 
532 50 m 154 90 37.9 11 2.09 1.79 0.86 4.19 2.43 80.8 201.1 170 
536 40 m 170 104 36 6 2.19 2.03 0.93 2.73 2.53 87 417.5 220 
537 46 m 154 62 26.1 5 2.69 2.36 0.87 5.08 2.99 49 740.7 400 
545 43 m 154 70 29.5 10 2.21 2.21 1 5.01 4.58 91.1 204 240 
553 38 m 164 64 23.8 11 2.52 2.27 0.9 6.57 3.15 69.8 418.89 480 
554 37 m 163 83 31.2 11 2.13 1.91 0.9 2.72 1.93 81.3 992.8 450 
555 43 m 167 74 26.5 7 2.83 2.8 0.99 8.52 4.88 106.1 148.7 440 
556 46 m 148 63 28.8 12 2.59 2.42 0.93 8.74 3.24 95.2 138.1 240 
 
